Form 424B2 EXACT SCIENCES CORP

Go back to Form 424B2 EXACT SCIENCES CORP

UBS Downgrades Exact Sciences (EXAS) to Neutral

October 29, 2020 6:11 AM EDT

UBS analyst Dan Brennan downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Neutral with a price target of $140.00 (from $125.00).

The analyst comments "We like the Thrive Deal on many levels, though timelines are lengthy & visibility limited. With COVID-19 pressuring the base business, plus... More